Horsham Water&Sewer Authority

PFAS monitoring results for a public water system in Pennsylvania

PA1460033UCMR 5EPA monitoring data
17.5Highest PFOA result, ppt
33.8Highest PFOS result, ppt
1.063Highest Hazard Index
780Results
PWSID
PA1460033
State
Pennsylvania
System type
community water system (CWS)
Population served
26,000
City
Horsham
Counties
Montgomery County
Primary source water
surface water (purchased)
UCMR 5 sampling
2024-02-20 to 2025-08-18 · 11 entry point(s) · water types: GW;SW
Service-area boundary
authoritative

PFOS ≥ 3 × its limit highest single result
PFOS ≥ 3 × its limit worst entry-point average

These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.

Water purchased from

  • North Wales Water Authority (PA1460048)
    Seller's highest results: PFOA 13 ppt · PFOS 11.1 ppt · HI 0.563 · detected: PFBA;PFBS;PFHpA;PFHxA;PFHxS;PFNA;PFOA;PFOS;PFPeA
  • Aqua Pa Main System (PA1460073)
    Seller's highest results: PFOA 12.6 ppt · PFOS 9.2 ppt · HI 1.203 · detected: PFBA;PFBS;PFHpA;PFHxA;PFHxS;PFNA;PFOA;PFOS;PFPeA

Seller results are the seller's own entry-point samples, not measurements of this system's water. This system's own samples (below) may reflect purchased water, its own sources, or both.

Compared with EPA's 2024 values

Highest single resultWorst entry-point average*Limit
PFOA (ppt)17.58.754
PFOS (ppt)33.816.94
Hazard Index1.0630.5311.0†

“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).

Compared with Pennsylvania standards

Highest single resultWorst entry-point average*Pennsylvania
PFOA (ppt)17.58.7514
PFOS (ppt)33.816.918

Sum standards add the listed compounds within each sample (non-detects = 0). State compliance is normally judged on averages over time; these are screening comparisons.

Sampling history

Sampled 2024-02-20 to 2025-08-18 · 11 entry point(s) · water types: GW;SW · 27 sampling visits. PFAS in ppt (ng/L).

DateEntry pointEventPFOAPFOSHIOther detections
2024-02-20Well #20 Treatment (GW)SE1<4<40PFBA 7.6, PFPeA 3.6
2024-02-20Well #26 Treatment (GW)SE1<4<40PFBA 41.4, PFPeA 65.3
2024-02-20Well #40 Treatment (GW)SE1<4<40none
2024-02-21Aqua Main Connection (SW)SE1<4<40PFBA 5.9, PFPeA 7.6
2024-02-21Well #19 Treatment (GW)SE1<4<40none
2024-02-21Well #2 Treatment (GW)SE1n/an/an/alithium 13.9 µg/L
2024-02-21Well #4 Treatment (GW)SE1<4<40none
2024-02-22Well #10 Treatment (GW)SE1<4<40none
2024-02-22Well #17 Treatment (GW)SE1<4<40none
2024-08-05Well #10 Treatment (GW)SE2<4<40PFBA 5.8, PFPeA 4.6
2024-08-05Well #2 Treatment (GW)SE2<4<40lithium 12.5 µg/L
2024-08-06Well #21 Treatment (GW)SE1<4<40PFPeA 3.5
2024-08-06Well #40 Treatment (GW)SE2<4<40none
2024-08-13Aqua Main Connection (SW)SE3<4<40none
2024-08-13NWWA Connection (SW)SE3<4<40none
2024-08-19Well #19 Treatment (GW)SE2<4<40none
2024-08-19Well #4 Treatment (GW)SE2<4<40PFBA 6.2, PFPeA 3.3
2024-08-20Well #17 Treatment (GW)SE2<4<40PFBA 10.9, PFPeA 16.9
2024-08-20Well #20 Treatment (GW)SE2<4<40none
2024-08-20Well #26 Treatment (GW)SE2<4<40PFBA 19.8
2024-11-12Aqua Main Connection (SW)SE4<4<40none
2024-11-12NWWA Connection (SW)SE4<4<40none
2024-12-16Well #2 Treatment (GW)SE117.533.81.063PFBA 5.9, PFHpA 4.4, PFHxA 7.1, PFPeA 7.4
2025-02-03Well #21 Treatment (GW)SE2<4<40PFPeA 5.3
2025-05-28Aqua Main Connection (SW)SE2<4<40none
2025-05-28NWWA Connection (SW)SE1<4<40none
2025-08-18NWWA Connection (SW)SE2<4<40none

“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).

All results by entry point

780 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.

Aqua Main Connection facility 00117 · sample point 117 · surface water

CompoundMRL2024-02-21
SE1
2024-08-13
SE3
2024-11-12
SE4
2025-05-28
SE2
PFBA5 ppt5.9< 5< 5< 5
PFPeA3 ppt7.6< 3< 3< 3
11Cl-PF3OUdS5 ppt< 5< 5< 5< 5
4:2 FTS3 ppt< 3< 3< 3< 3
6:2 FTS5 ppt< 5< 5< 5< 5
8:2 FTS5 ppt< 5< 5< 5< 5
9Cl-PF3ONS2 ppt< 2< 2< 2< 2
ADONA3 ppt< 3< 3< 3< 3
HFPO-DA5 ppt< 5< 5< 5< 5
NEtFOSAA5 ppt< 5< 5< 5< 5
NFDHA20 ppt< 20< 20< 20< 20
NMeFOSAA6 ppt< 6< 6< 6< 6
PFBS3 ppt< 3< 3< 3< 3
PFDA3 ppt< 3< 3< 3< 3
PFDoA3 ppt< 3< 3< 3< 3
PFEESA3 ppt< 3< 3< 3< 3
PFHpA3 ppt< 3< 3< 3< 3
PFHpS3 ppt< 3< 3< 3< 3
PFHxA3 ppt< 3< 3< 3< 3
PFHxS3 ppt< 3< 3< 3< 3
PFMBA3 ppt< 3< 3< 3< 3
PFMPA4 ppt< 4< 4< 4< 4
PFNA4 ppt< 4< 4< 4< 4
PFOA4 ppt< 4< 4< 4< 4
PFOS4 ppt< 4< 4< 4< 4
PFPeS4 ppt< 4< 4< 4< 4
PFTA8 ppt< 8< 8< 8< 8
PFTrDA7 ppt< 7< 7< 7< 7
PFUnA2 ppt< 2< 2< 2< 2
lithium9 µg/L< 9< 9< 9< 9

NWWA Connection facility 00118 · sample point 118 · surface water

CompoundMRL2024-08-13
SE3
2024-11-12
SE4
2025-05-28
SE1
2025-08-18
SE2
11Cl-PF3OUdS5 ppt< 5< 5< 5< 5
4:2 FTS3 ppt< 3< 3< 3< 3
6:2 FTS5 ppt< 5< 5< 5< 5
8:2 FTS5 ppt< 5< 5< 5< 5
9Cl-PF3ONS2 ppt< 2< 2< 2< 2
ADONA3 ppt< 3< 3< 3< 3
HFPO-DA5 ppt< 5< 5< 5< 5
NEtFOSAA5 ppt< 5< 5< 5< 5
NFDHA20 ppt< 20< 20< 20< 20
NMeFOSAA6 ppt< 6< 6< 6< 6
PFBA5 ppt< 5< 5< 5< 5
PFBS3 ppt< 3< 3< 3< 3
PFDA3 ppt< 3< 3< 3< 3
PFDoA3 ppt< 3< 3< 3< 3
PFEESA3 ppt< 3< 3< 3< 3
PFHpA3 ppt< 3< 3< 3< 3
PFHpS3 ppt< 3< 3< 3< 3
PFHxA3 ppt< 3< 3< 3< 3
PFHxS3 ppt< 3< 3< 3< 3
PFMBA3 ppt< 3< 3< 3< 3
PFMPA4 ppt< 4< 4< 4< 4
PFNA4 ppt< 4< 4< 4< 4
PFOA4 ppt< 4< 4< 4< 4
PFOS4 ppt< 4< 4< 4< 4
PFPeA3 ppt< 3< 3< 3< 3
PFPeS4 ppt< 4< 4< 4< 4
PFTA8 ppt< 8< 8< 8< 8
PFTrDA7 ppt< 7< 7< 7< 7
PFUnA2 ppt< 2< 2< 2< 2
lithium9 µg/L< 9< 9< 9< 9

Well #10 Treatment facility 00109 · sample point 109 · groundwater

CompoundMRL2024-02-22
SE1
2024-08-05
SE2
PFBA5 ppt< 55.8
PFPeA3 ppt< 34.6
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #17 Treatment facility 00110 · sample point 110 · groundwater

CompoundMRL2024-02-22
SE1
2024-08-20
SE2
PFBA5 ppt< 510.9
PFPeA3 ppt< 316.9
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #19 Treatment facility 00111 · sample point 111 · groundwater

CompoundMRL2024-02-21
SE1
2024-08-19
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #2 Treatment facility 00102 · sample point 102 · groundwater

CompoundMRL2024-02-21
SE1
2024-08-05
SE2
2024-12-16
SE1
PFBA5 ppt–< 55.9
PFBS3 ppt–< 35.7
PFHpA3 ppt–< 34.4
PFHxA3 ppt–< 37.1
PFHxS3 ppt–< 310.6
PFOA4 ppt–< 417.5
PFOS4 ppt–< 433.8
PFPeA3 ppt–< 37.4
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5< 5–
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6< 6–
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8< 8–
PFTrDA7 ppt< 7< 7–
PFUnA2 ppt–< 2< 2
lithium9 µg/L13.912.5–

Well #20 Treatment facility 00112 · sample point 112 · groundwater

CompoundMRL2024-02-20
SE1
2024-08-20
SE2
PFBA5 ppt7.6< 5
PFPeA3 ppt3.6< 3
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #21 Treatment facility 00115 · sample point 115 · groundwater

CompoundMRL2024-08-06
SE1
2025-02-03
SE2
PFPeA3 ppt3.55.3
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #26 Treatment facility 00114 · sample point 114 · groundwater

CompoundMRL2024-02-20
SE1
2024-08-20
SE2
PFBA5 ppt41.419.8
PFPeA3 ppt65.3< 3
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #4 Treatment facility 00104 · sample point 104 · groundwater

CompoundMRL2024-02-21
SE1
2024-08-19
SE2
PFBA5 ppt< 56.2
PFPeA3 ppt< 33.3
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well #40 Treatment facility 00116 · sample point 116 · groundwater

CompoundMRL2024-02-20
SE1
2024-08-06
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Statistics by compound

CompoundResultsDetectedHighest (date)Mean boundsKM medianP75P90P95
PFPeA2635%65.3
2024-02-20
4.52–6.48<MRL3.67.616.9
PFBA2631%41.4
2024-02-20
3.98–7.44<MRL5.910.919.8
lithium268%13.9
2024-02-21
1.02–9.32<MRL<MRL<MRL12.5
PFBS264%5.7
2024-12-16
0.22–3.1<MRL<MRL<MRL<MRL
PFHpA264%4.4
2024-12-16
0.17–3.05<MRL<MRL<MRL<MRL
PFHxA264%7.1
2024-12-16
0.27–3.16<MRL<MRL<MRL<MRL
PFHxS264%10.6
2024-12-16
0.41–3.29<MRL<MRL<MRL<MRL
PFOA264%17.5
2024-12-16
0.67–4.52<MRL<MRL<MRL<MRL
PFOS264%33.8
2024-12-16
1.3–5.15<MRL<MRL<MRL<MRL

Never detected (21): 11Cl-PF3OUdS, 4:2 FTS, 6:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFDA, PFDoA, PFEESA, PFHpS, PFMBA, PFMPA, PFNA, PFPeS, PFTA, PFTrDA, PFUnA.

Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.

Sources

  • EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-10 to 2026-04-09; data summary dated Jul 2026)
  • EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
  • EPA Public Water System Service Areas v3 (Mar 2026)
  • US Census Bureau cartographic boundary counties 1:500k, 2024
  • EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+

Data build 52bd2907cbc3 · 2026-10-18T04:10Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.